2-azetidinyl-7-methyl-8-oxo-6-(trifluoromethyl)-7,8-dihydropyrimido[5,4-d]pyrimidine derivatives as trem2 modulators for the treatment of neurodegenerative diseases
IL328677APending Publication Date: 2026-07-01MUNA THERAPEUTICS APS +2
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- IL · IL
- Patent Type
- Applications
- Current Assignee / Owner
- MUNA THERAPEUTICS APS
- Filing Date
- 2026-05-26
- Publication Date
- 2026-07-01
Need to check novelty before this filing date? Find Prior Art
No text content released.